| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 12/01/2005 | US20050267212 Omega-3 fatty acids in the treatment of depression |
| 12/01/2005 | US20050267204 Synergistic gold-containing compositions |
| 12/01/2005 | US20050267022 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 12/01/2005 | US20050266098 Composition for treatment of a hydrofluoric acid burn |
| 12/01/2005 | US20050266096 New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
| 12/01/2005 | US20050266095 Gentle preservative compositions |
| 12/01/2005 | US20050266094 Topical composition and method for the treatment and prophylaxis of dermal irritations |
| 12/01/2005 | US20050266089 Contact lens and eye drop rewetter compositions and methods |
| 12/01/2005 | US20050266081 Antimicrobial silver hydrogels |
| 12/01/2005 | US20050266076 Resorbable delivery systems for the treatment of cancer |
| 12/01/2005 | US20050266035 Skin protectant spray compositions |
| 12/01/2005 | US20050266018 Nutraceutical compositions with mangosteen |
| 12/01/2005 | CA2567329A1 Rapid setting calcium phosphate cements |
| 12/01/2005 | CA2567297A1 Tissue sealant |
| 12/01/2005 | CA2566174A1 Treatment of lung diseases and pre-lung disease conditions |
| 11/30/2005 | EP1599198A1 Potassium taurate bicarbonate and ascorbate complexes |
| 11/30/2005 | EP1599189A1 Control release formulation containing a hydrophobic material as the sustained release agent |
| 11/30/2005 | EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 11/30/2005 | EP1313488A4 Compositions and methods for improving cardiovascular function |
| 11/30/2005 | EP0951470B1 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients |
| 11/30/2005 | CN1701815A Anti-caries oral compositions |
| 11/30/2005 | CN1229110C Ophthalmic compositions containing galactomannan polymers and borate |
| 11/29/2005 | CA2308532C Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 11/24/2005 | WO2005110444A1 Therapeutic or preventive agent for eye disease |
| 11/24/2005 | WO2005110443A1 Antiviral agent |
| 11/24/2005 | WO2005110442A2 Peritoneal dialysis solution |
| 11/24/2005 | WO2005110441A2 Intermittent dosing of nitric oxide gas |
| 11/24/2005 | WO2005110388A1 Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 11/24/2005 | WO2005110376A2 Rapidly disintegrating tablets comprising titanium dioxide |
| 11/24/2005 | WO2005110375A1 Nutritional supplement for treatment of ocular diseases |
| 11/24/2005 | WO2005110347A1 Composition, compising hydrofluoric acid, for inhibiting dental erosion |
| 11/24/2005 | WO2005110339A1 Composition containing nano-crystalline apatite |
| 11/24/2005 | WO2005110114A1 Liquid nutritional supplement and method for preparing same |
| 11/24/2005 | WO2005110090A1 Hydrogen peroxide-based skin disinfectant |
| 11/24/2005 | WO2005039648A3 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 11/24/2005 | US20050261240 Carrageenan based antimicrobial compositions |
| 11/24/2005 | US20050260288 Suppress cancer with complication by Canavalia ensiformis extract |
| 11/24/2005 | US20050260285 Healthy prostate formula |
| 11/24/2005 | US20050260283 Composition for prevention and treatment of colon adenomas |
| 11/24/2005 | US20050260282 Novel hypoglycemic agent, diabetes preventive agent, deep sea water concentrate, and method for producing deep sea water concentrate |
| 11/24/2005 | US20050260281 Upper respiratory tract virus infection preventive therapy |
| 11/24/2005 | US20050260280 Contact lens and eye drop rewetter compositions and methods |
| 11/24/2005 | US20050260279 Rapid setting calcium phosphate cements |
| 11/24/2005 | US20050260278 Dry reactants that include calcium and phosphate sources, as well as a monovalent cation dihydrogen phosphate salt, are combined with a setting fluid and the combined reactants are mixed to produce the settable formulation |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260271 Composition comprising layered host material with intercalated functional-active organic compound |
| 11/24/2005 | US20050260269 Composition containing nano-crystalline apatite |
| 11/24/2005 | US20050260265 Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture |
| 11/24/2005 | US20050260257 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions |
| 11/24/2005 | US20050260249 Antimicrobial contact lenses and methods for their production |
| 11/24/2005 | DE202005012984U1 Oral combination, useful in the treatment and/or prophylaxis of eye diseases e.g. glaucoma, comprises one or more dosage units comprising e.g. zinc oxide; highly purified fish oil; ascorbic acid and optionally carotenoid, cinnamon |
| 11/24/2005 | CA2566408A1 Composition, comprising hydrofluoric acid, for inhibiting dental erosion |
| 11/24/2005 | CA2566347A1 Composition containing nano-crystalline apatite |
| 11/24/2005 | CA2566326A1 Peritoneal dialysis solution |
| 11/24/2005 | CA2566180A1 Use of targeted oxidative therapeutic formulation in treatment of cancer |
| 11/24/2005 | CA2563493A1 Intermittent dosing of nitric oxide gas |
| 11/23/2005 | EP1598072A1 Medical drug containing fine particle of noble metal |
| 11/23/2005 | EP1598071A1 Superoxide anion decomposing agent |
| 11/23/2005 | EP1598063A1 Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids |
| 11/23/2005 | EP1597171A2 Therapeutic microfoam |
| 11/23/2005 | EP1596962A2 Gas accumulator for storing a predetermined gas quantity and for releasing said gas for medical use |
| 11/23/2005 | EP1596876A1 Use of pvp-iodine liposomes for treatment of acne |
| 11/23/2005 | EP1596854A2 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| 11/23/2005 | EP1596827A2 Use of pvp-iodine liposomes for treatment of herpes |
| 11/23/2005 | EP1596826A1 Use of pvp-iodine liposomes for treatment of atopic dermatitis |
| 11/23/2005 | EP1596821A2 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 11/23/2005 | EP1596815A2 Composition and methods for inhibiting cell survival |
| 11/23/2005 | EP1330226A4 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 11/23/2005 | EP1163528B1 Prediction of diabetes impaired wound healing |
| 11/23/2005 | CN1698650A Arsenious acid injection for treating primary carcinoma of liver and preparation method thereof |
| 11/23/2005 | CN1698649A Oral zinc reinforcing agent using hydrotalcite as carrier, its preparation and using method thereof |
| 11/23/2005 | CN1698648A Montmorillonite dispersed tablet and preparation technique thereof |
| 11/23/2005 | CN1228055C Multi-function medicine for beautifying and treating scald by boiled water or fire and cold injury |
| 11/22/2005 | US6967031 silymarin, salicin, at least one B vitamin, magnesium, molybdenum and manganese; for ingestion prior to, during, or after the consumption of the alcohol |
| 11/22/2005 | US6967030 Formulation for insulin and glucose control |
| 11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 11/22/2005 | US6967002 Method and apparatus for producing a sterile fluid |
| 11/20/2005 | CA2467894A1 A composition for prevention and treatment of colon adenomas |
| 11/17/2005 | WO2005108548A2 Anti-microbial carrier systems |
| 11/17/2005 | WO2005107826A2 Initially plastically deformable bone implant compositions |
| 11/17/2005 | WO2005107775A1 Composition having effect of modulating autonomic nerves and method of using the same |
| 11/17/2005 | WO2005107774A1 Pharmaceutical wound healing composition |
| 11/17/2005 | WO2005107744A1 Nerve damage |
| 11/17/2005 | WO2005107722A2 Directly compressible tricalcium phosphate |
| 11/17/2005 | WO2005107713A2 Swellable dosage form comprising gellan gum |
| 11/17/2005 | US20050256031 Composition for relieving discomfort |
| 11/17/2005 | US20050255509 In vivo measurement of the relative fluxes through ribonucleotide reductase vs. deoxyribonucleoside pathways using isotopes |
| 11/17/2005 | US20050255178 Enhancing the effectiveness of an inhaled therapeutic gas |
| 11/17/2005 | US20050255177 Method for attenuating free radical formation resulting from bodily insult |
| 11/17/2005 | US20050255176 Method for attenuating free radical formation resulting from bodily insult |
| 11/17/2005 | US20050255175 Method for protecting nephron against injury caused by disruption of a chemical environment in the kidneys |
| 11/17/2005 | US20050255174 Process and appratus for use in preparing an aqueous magnesium bicarbonate solution |
| 11/17/2005 | US20050255173 Anticancer composition |
| 11/17/2005 | US20050255172 Hydrogen peroxide-based skin disinfectant |
| 11/17/2005 | US20050255169 Adjuvant containing xenon |
| 11/17/2005 | US20050255168 Cerebral protection with a gas comprising xenon |
| 11/17/2005 | US20050255159 comprising hydroxyapatite material made from mixture of calcium phosphate, calcium oxide and removable inorganic porogen such as iron oxide; biomimetics; biocompatible, biodegradable |
| 11/17/2005 | US20050255071 Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
| 11/17/2005 | US20050255065 Aluminium and hexamethylenetetramine complex and the applications thereof |
| 11/17/2005 | CA2565840A1 High yield and rapid syntheses methods for producing metallo-organic salts |